Inspirna, Inc.
Biotechnology company · New York, United States
Inspirna, Inc. is a biotechnology company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $55 million sold in a notice filed in 2022.
Profile compiled from public records. Is this your company? Request a correction or update
Inspirna at a glance
Typebiotechnology company
HeadquartersNew York, United States
SEC CIK1651159
What does Inspirna do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $55.1 million sold (2022).
Frequently asked questions about Inspirna
Where is Inspirna headquartered?
Inspirna, Inc. is headquartered in New York, United States.
What does Inspirna do?
Inspirna, Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences